SCORE

70

BEAT: BIOTELEMETRY INC is a Buy


The current rating for BEAT is 70, which is 40% above its historic median rating of 50. This indicates lower risk than normal.


The rating is currently showing a higher than normal reading, suggesting risk levels could be lower than normal.